Sentinel lymph node biopsy in patients with ductal carcinoma in situ: A proposal

Kelly M. McMasters; Celia Chao; Sandra L. Wong; Robert C.G. Martin; Michael J. Edwards

doi:10.1002/cncr.10641

Sentinel lymph node biopsy in patients with ductal carcinoma in situ: A proposal

Kelly M. McMasters, Celia Chao, Sandra L. Wong, Robert C.G. Martin, Michael J. Edwards

Research output: Contribution to journal › Review article › peer-review

47 Scopus citations

Abstract

Sentinel lymph node (SLN) biopsy for the treatment of ductal carcinoma in situ (DCIS) is not necessary and generally should be limited to those patients with a core needle biopsy diagnosis of DCIS who are undergoing mastectomy. Used in this way, SLN biopsy will spare the majority of patients with occult invasive tumor the need for axillary lymph node dissection.

Original language	English (US)
Pages (from-to)	15-20
Number of pages	6
Journal	Cancer
Volume	95
Issue number	1
DOIs	https://doi.org/10.1002/cncr.10641
State	Published - Jul 1 2002
Externally published	Yes

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1002/cncr.10641

Cite this

@article{0b867a6d0a41470cb18c84da0a4120db,

title = "Sentinel lymph node biopsy in patients with ductal carcinoma in situ: A proposal",

abstract = "Sentinel lymph node (SLN) biopsy for the treatment of ductal carcinoma in situ (DCIS) is not necessary and generally should be limited to those patients with a core needle biopsy diagnosis of DCIS who are undergoing mastectomy. Used in this way, SLN biopsy will spare the majority of patients with occult invasive tumor the need for axillary lymph node dissection.",

author = "McMasters, {Kelly M.} and Celia Chao and Wong, {Sandra L.} and Martin, {Robert C.G.} and Edwards, {Michael J.}",

year = "2002",

month = jul,

day = "1",

doi = "10.1002/cncr.10641",

language = "English (US)",

volume = "95",

pages = "15--20",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

number = "1",

}

TY - JOUR

T1 - Sentinel lymph node biopsy in patients with ductal carcinoma in situ

T2 - A proposal

AU - McMasters, Kelly M.

AU - Chao, Celia

AU - Wong, Sandra L.

AU - Martin, Robert C.G.

AU - Edwards, Michael J.

PY - 2002/7/1

Y1 - 2002/7/1

N2 - Sentinel lymph node (SLN) biopsy for the treatment of ductal carcinoma in situ (DCIS) is not necessary and generally should be limited to those patients with a core needle biopsy diagnosis of DCIS who are undergoing mastectomy. Used in this way, SLN biopsy will spare the majority of patients with occult invasive tumor the need for axillary lymph node dissection.

AB - Sentinel lymph node (SLN) biopsy for the treatment of ductal carcinoma in situ (DCIS) is not necessary and generally should be limited to those patients with a core needle biopsy diagnosis of DCIS who are undergoing mastectomy. Used in this way, SLN biopsy will spare the majority of patients with occult invasive tumor the need for axillary lymph node dissection.

UR - http://www.scopus.com/inward/record.url?scp=0036644987&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036644987&partnerID=8YFLogxK

U2 - 10.1002/cncr.10641

DO - 10.1002/cncr.10641

M3 - Review article

C2 - 12115311

AN - SCOPUS:0036644987

VL - 95

SP - 15

EP - 20

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 1

ER -

Sentinel lymph node biopsy in patients with ductal carcinoma in situ: A proposal

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this